公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2014 | erratum: Oxidative stress enhances AXL-mediated cell migration through AKT1/Rac1-dependent mechanism (Free Radical Biology and Medicine (2013) 65 (1246-1256)) | Huang J.-S.; Cho C.-Y.; Hong C.-C.; Yan M.-D.; Hsieh M.-C.; Lay J.-D.; Lai G.-M.; ANN-LII CHENG ; Chuang S.-E. | Free Radical Biology and Medicine | 0 | 0 | |
1998 | Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen | ANN-LII CHENG ; Chuang S.-E.; Fine R.L.; KUN-HUEI YEH ; Liao C.-M.; Lay J.-D.; Chen D.-S. | Biochemical Pharmacology | 69 | 65 | |
2016 | Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells | Cho C.-Y.; Huang J.-S.; Shiah S.-G.; Chung S.-Y.; Lay J.-D.; Yang Y.-Y.; Lai G.-M.; ANN-LII CHENG ; Chen L.-T.; Chuang S.-E. | RNA | 33 | 32 | |
2013 | Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanism | Huang J.-S.; Cho C.-Y.; Hong C.-C.; Yan M.-D.; Hsieh M.-C.; Lay J.-D.; Lai G.-M.; ANN-LII CHENG ; Chuang S.-E. | Free Radical Biology and Medicine | 46 | 39 | |
2008 | Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia | Hong C.-C.; Lay J.-D.; Huang J.-S.; ANN-LII CHENG ; JIH-LUH TANG ; Lin M.-T.; Lai G.-M.; Chuang S.-E. | Cancer letters | 182 | 165 | |
2007 | Sulfasalazine suppresses drug resistance and invasiveness of lung adenocarcinoma cells expressing AXL | Lay J.-D.; Hong C.-C.; Huang J.-S.; Yang Y.-Y.; Pao C.-Y.; Liu C.-H.; Lai Y.-P.; Lai G.-M.; ANN-LII CHENG ; Su I.-J.; Chuang S.-E. | Cancer Research | 97 | 86 | |
1994 | Use of retinoic acids in the treatment of peripheral T-cell lymphoma: A pilot study | ANN-LII CHENG ; Su I.-J.; Chen C.-C.; HWEI-FANG TIEN ; Lay J.-D.; Chen B.-R.; YEONG-SHIAU PU ; RUEY-LONG HONG ; MING-CHING SHEN ; Wang C.-H.; YAO-CHANG CHEN | Journal of Clinical Oncology | 50 | 46 |